Kumar Sambamurti to Glucagon-Like Peptide-1 Receptor
This is a "connection" page, showing publications Kumar Sambamurti has written about Glucagon-Like Peptide-1 Receptor.
Connection Strength
0.087
-
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement. 2014 Feb; 10(1 Suppl):S62-75.
Score: 0.029
-
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. J Alzheimers Dis. 2010; 19(4):1205-19.
Score: 0.022
-
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1285-90.
Score: 0.021
-
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci. 2004 Dec; 1035:290-315.
Score: 0.015